Research advances in susceptibility genes of non-alcoholic fatty liver disease and its association with type 2 diabetes

CORC > 上海药物研究所 > 中国科学院上海药物研究所 > 药物安全性评价中心

	Research advances in susceptibility genes of non-alcoholic fatty liver disease and its association with type 2 diabetes
	Du Te 4; Chen Jing4 ; Shen Xu1
刊名	Journal of China Pharmaceutical University
	2018
卷号	49 期号:5 页码:537-544
关键词	nonalcoholic fatty liver disease type 2 diabetes mellitus susceptibility genes correlation
ISSN号	1000-5048
其他题名	非酒精性脂肪肝病的易感基因及与2型糖尿病相关性的研究进展
文献子类	Review
英文摘要	Nonalcoholic fatty liver disease (NAFLD) as the most common hepatic disease worldwide is affected not only by extrinsic factors,but also by genetic ones.Type 2 diabetes mellitus(T2DM),another chronic disease regulated by both environmental and genetic factors,is closely related to NAFLD in signal pathways and susceptibility genes.This review summarizes the susceptibility genes of NAFLD,especially points out their relevance to T2DM and suggests their related clinical applications,which provide further evidence for the exploration of the mechanisms of the two diseases with a new direction for their diagnosis and treatment.
WOS研究方向	General & Internal Medicine (provided by Clarivate Analytics)
语种	中文
CSCD记录号	CSCD:6349772
内容类型	期刊论文
源URL	[http://119.78.100.183/handle/2S10ELR8/269151]
专题	药物安全性评价中心
通讯作者	Chen Jing
作者单位	1.Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, China. 2.Shanghai; 3.; 4.Shanghai Institute of Materia Medica,Chinese Academy of Sciences;
推荐引用方式 GB/T 7714	Du Te,Chen Jing,Shen Xu. Research advances in susceptibility genes of non-alcoholic fatty liver disease and its association with type 2 diabetes[J]. Journal of China Pharmaceutical University,2018,49(5):537-544.
APA	Du Te,Chen Jing,&Shen Xu.(2018).Research advances in susceptibility genes of non-alcoholic fatty liver disease and its association with type 2 diabetes.Journal of China Pharmaceutical University,49(5),537-544.
MLA	Du Te,et al."Research advances in susceptibility genes of non-alcoholic fatty liver disease and its association with type 2 diabetes".Journal of China Pharmaceutical University 49.5(2018):537-544.